TDOC Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $5.52
Market Cap (MRQ) $1.00B
P/E (TTM) -5.6
EPS (TTM) $-0.99
Revenue (TTM) $2.49B
ROE (TTM) -13.0%
52W Range $4–$10

TDOC Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

About Teladoc Health, Inc. Common Stock Company overview from Wikipedia

05 · wikidata

Teladoc Health, Inc. is an American telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services.

The company uses telephone and videoconferencing software and mobile apps to provide on-demand remote medical care. Teladoc Health is active in over 175 countries, and is traded on the New York Stock Exchange. It is the first and largest telemedicine company in the United States, and has acquired numerous other companies including BetterHelp in 2015, Best Doctors in 2017, and Catapult Health in 2025.

History

2002–2015

Teladoc was founded in 2002 in Dallas, Texas by G. Byron Brooks and Michael Gorton. It is the oldest and largest telemedicine company in the United States. Teladoc's initial business model allowed patients to remotely consult with state-licensed doctors at any time. Companies paid a monthly fee for their employees to access the service, while patients paid a flat fee for each consultation, originally about $35 to $40. With Gorton as both chairman and CEO, Teladoc launched nationally in 2005 at the Consumer Directed Health Care Conference in Chicago, Illinois. Teladoc had around 1 million members by the end of 2007, with large employers such as AT&T providing the service to employees as a health benefit. Jason Gorevic was named Teladoc's chief executive in 2009. In 2011, Aetna began offering Teladoc for its fully insured members in Florida and Texas, later offering Teladoc in all 50 states.

Teladoc acquired Consult A Doctor for $16.6 million cash in 2013, allowing smaller companies to access Teladoc's services. The Affordable Care Act led to a large number of insurance companies signing with Teladoc, resulting in a growth surge around 2014. By that time, insurance companies such as Blue Shield of California and Oscar had signed with Teladoc, as well as other companies such as Home Depot, T-Mobile, CalPERS, and Rent-A-Center. Teladoc acquired AmeriDoc for $17.2 million in May 2014. The acquisitions of Consult A Doctor and AmeriDoc, both Teladoc's main competitors, resulted in Teladoc becoming the largest telemedicine provider in the United States. After initial fundraising rounds in 2009, 2011, and 2013, Teladoc raised $50 million in 2014, bringing total funding to $100 million. Teladoc's sales doubled in both 2013 and 2014.

2015–2016

Teladoc Health became a public company on July 1, 2015 as the only telemedicine company on the New York Stock Exchange. Teladoc's initial public offering listed at $19 per share, giving the company a market capitalization of $758 million and an enterprise value of $620 million. The initial response to the IPO was positive, as shares surged 50% on the opening day. Three months after the IPO, health insurer Highmark, which represented 1.5% of Teladoc's 2015 revenue, ceased to renew a contract. Teladoc shares fell significantly as a result, before rising to earlier levels. That October, it was the first telehealth company to reach one million visits.

In 2015, Teladoc acquired the behavioral health services provider Compile Inc., operating as BetterHelp for $3.5 million, and competitor Stat Health Services (StatDoc) for $30 million. The following year Teladoc began aggressively expanding, acquiring other companies and launching health segments for dermatology, behavioral health, and sexual health. That year the company won a patent infringement lawsuit filed against competitor American Well.

In July 2016, Teladoc acquired HealthiestYou for $125 million ($45 million in cash and $80 million in stock). Teladoc had 15 million members by November 2016 and a market share of 75% in the United States. The largest national network of virtual care providers in the nation, its full-service suite was operational in 48 states, excluding Arkansas and Texas. In December 2016, the American Hospital Association exclusively endorsed Teladoc's telehealth technology platform. Teladoc logged 952,000 patient visits that year.

2017–2020

In its largest acquisition at the time, in 2017 Teladoc spent $440 million purchasing Best Doctors, a consultation firm and provider of medical second opinions and medical award listings. In 2019, ProPublica criticized companies such as Best Doctors for selling physician awards as pay-to-play. Teladoc had 7,500 clients in 2017, of which 220 were Fortune 1000 companies. Sales that year were $233 million, 89% higher than the year prior. Teladoc Health brands by 2018 included Teladoc, Advance Medical, Best Doctors, BetterHelp and HealthiestYou.

On August 10, 2018, Teladoc, Inc. changed its name to Teladoc Health, Inc. while continuing to trade on the NYSE. Teladoc Health began partnering with CVS in August 2018 on remote consults at MinuteClinics. Teladoc Health acquired Advance Medical, a telemedicine company employing doctors in Latin America, Europe, and Asia, for $352 million in 2018. In December 2018, Teladoc Health's chief financial officer and chief operating officer Mark Hirschhorn resigned after a report that he engaged in a sexual relationship and insider trading with an employee. According to Yahoo Finance, stock value fell roughly 20% in the days following, while an investor class action lawsuit alleged that Teladoc Health had violated securities laws by failing to disclose Hirschhorn's behavior. Teladoc Health denied making false statements or any legal violations.

Active in 130 countries by 2019; that year, Teladoc acquired the French health company MédecinDirect and launched in Canada with the Teladoc Telemedicine Service. Joining from American Express, Mala Murthy was appointed CFO in June 2019.

In March 2020, Teladoc was providing "near real-time" surveillance data on the spread of coronavirus to the CDC. In July 2020, Teladoc acquired InTouch Health. In October 2020, Teladoc acquired the chronic care company Livongo Health for $13.9 billion in a deal described by the press as the third-largest for a U.S. company that year. The combined companies had an estimated enterprise value of $37 billion. Teladoc then brought in Florida Blue as the first insurer to use Livongo's digital diabetes program. Teladoc sued Amwell in October 2020 for alleged copyright infringement on nine patents, settling the case in July 2022.

2021–2024

In early 2021, paid membership in the U.S. was 52 million. In January 2021, Teladoc began offering a diabetes management service through Dexcom. Later that year, Teladoc Health launched myStrength Complete, a "unified mental health care platform for its B2B customers." In June 2021, Teladoc sued the company Avail for allegedly infringing on three patents related to telemedicine consoles.

On July 14, 2021, Teladoc announced it was collaborating with Microsoft to combine its delivery platform for hospitals and health systems with Microsoft Teams. Teladoc introduced its primary care service Primary360 on a national scale in October 2021. The program gave members access to both a primary physician and care team, with a system in place for followup reminders about appointments and personal maintenance. In February 2022, Teladoc Health launched Chronic Care Complete, a program to help patients manage multiple chronic conditions.

Teladoc had a valuation of roughly $11.3 billion by February 2022, and warned investors there might be a goodwill write-down that year related to the Livongo acquisition. Teladoc announced that Amazon could newly access Teladoc through Alexa and related devices, in February 2022, sparking debate among antitrust experts about the potential impact on the health industry. Amazon Care was shut down later that year.

In April 2022, Northwell Health began using the Teladoc platform with its clinicians, starting with 20 hospitals in the system. After Teladoc's stock value fluctuated significantly during the coronavirus pandemic, the company, in June 2022, was sued by investors alleging it had misrepresented its financial prospects, particularly in regard to its BetterHelp mental health subsidiary and chronic care business. Characterizing the lawsuit, which was later dismissed, as "frivolous," in July 2022, Teladoc reported revenue growth above analysts' projections, with significant growth in BetterHelp. In August 2022, Teladoc became the telehealth portal for Mayo Clinic Health System patients in Onalaska, Wisconsin.

In 2023, the company relocated its headquarters to new York City. Charles "Chuck" Divita, III, was appointed CEO in June 2024, leading the company's further expansion. In July, the firm launched Wellbound employee assistance program (EAP), incorporating BetterHelp into its U.S. employer-sponsored health plans.

2025–present

In January 2025, the company added its virtual cardiometabolic programs to Amazon Health Services health benefits connector. That year, Teladoc Health made a series of acquisitions, including Catapult Health in February, mental healthcare company UpLift in April, and Australia's Telecare virtual care firm in August.

In March 2025, the FTC fined BetterHelp $7.8 million for sharing consumer data with third-party social media sites, banning the company from health data disclosures for advertising purposes. Subsequent to the dismissed June 2022 lawsuit, a new class-action was filed by investors in the U.S. District Court for the Southern District of New York on May 17, 2025.

The company reported over 100 million U.S. members in July 2025, and launched new AI capabilities for healthcare workplaces to monitor and mitigate violence that October. In November, Teladoc Health joined with Lumeris, Deloitte, Nuna and Unite Us as Collaborative for Healthy Rural America, pledging to build a shared, integrated care platform, following individual states' plan approvals from the new Rural Health Transformation (RHT) Program of the U.S. Department of Health and Human Services.

Services and business model

Headquartered in New York City, the company operates two main components: Teladoc Health Integrated Care, its virtual care business for health plans, employers and health networks, and BetterHelp direct-to-consumer virtual mental health care. As a technology company, Teladoc Health is involved with artificial intelligence, analytics, telehealth devices, and "licensable platform services." The company uses telephone and videoconferencing software to provide on-demand remote medical care, with patients able to log on to the service at any time and be connected with a board-certified, state-licensed physician. Its app combines all of its services and programs.

Contracting largely with insurers and large employers, hospitals and health systems, Teladoc Health generates revenue through an annual, or monthly, fee charged per subscriber, as well as a fee for individual consults. Some companies waive or subsidize the consult fee for their employees.

By July 2020, the company stated it served "60 of the top 100 hospitals," with telemedical robots being used at hospitals such as Providence Regional Medical Center in Everett, Washington and Sheba Medical Center in Israel, minimizing the potential spread of coronavirus. Numerous studies analyzing Teladoc's impact on the industry have been conducted.

Disaster aid

Teladoc Health provides free telehealth visits to communities affected by federally declared natural disasters and public emergencies in the United States, including to victims of incidents such as the 2018 Camp Fire in Paradise, California, Hurricane Ida in 2021, and the 2025 Southern California wildfires. In March 2023, it began providing free care to residents in Mississippi affected by recent tornadoes and, in 2024, to communities in several states that were impacted by Hurricanes Milton and Helene.

Lobbying and legislation

Teladoc Health has been involved in lobbying for legislation in several states. In 2015 the Texas Medical Board ruled that state physicians had to physically meet patients before remotely treating ailments or prescribing medication. The bill undermined Teladoc Health's business model in Texas, where it had around two million subscribers. Teladoc Health sued in federal court over the rule in Teladoc v. Texas Medical Board, arguing the bill violated antitrust laws by inflating prices and limiting the supply of health care providers in the state. The bill, meant to go active on June 3, 2015, was stalled while the lawsuit went through a federal appeals court, allowing Teladoc Health to continue operating in Texas in the interim. Teladoc voluntarily dropped the lawsuit in 2017 after Texas passed a new bill allowing for remote treatment without a prior in-person interaction, which Teladoc Health had lobbied heavily for.

In January 2019, Teladoc Health opposed a telemedicine bill proposed by the North Dakota Board of Medicine, which required telemedicine providers to perform initial video examinations or have initial exams done by another physician. Proponents argued the bill protected patients, while Teladoc Health and critics argued it decreased access to healthcare in rural areas. The year prior, Teladoc Health had completed 1,500 virtual visits in the state. In May 2019, the company created a virtual care patient safety organization (PSO) dubbed the Institute for Patient Safety and Quality of Virtual Care.

In December 2021, Teladoc along with the American Medical Association, American Hospital Association, AARP, Amazon, Walmart, and CVS formed Telehealth Access for America, a coalition pushing for the extension of telehealth policies implemented by U.S. Congress in response to the COVID-19 pandemic. Subsequently, U.S. Senators Bill Cassidy and Tammy Baldwin introduced the Health Data Use and Privacy Commission Act in February 2022, which proposes creating a commission to study modernizing health data and privacy laws. The proposed legislation was supported by Teladoc and organizations such as the American College of Cardiology, IBM, and the United Spinal Association.

Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗

Wikidata ↗

sectorHealth Care industryHealth Care employees4,648 countryUS

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$2.53B
2016-12-31 → 2025-12-31
EPS$-1.14
2019-12-31 → 2025-12-31
Free Cash Flow$285M
2017-12-31 → 2025-12-31
Net margin-7.1%
2017-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend TDOC 5Y avg Peer Median Verdict
P/E (TTM) -5.65Y avg ≈-11.5 ≈-11.5 · ·
P/S (TTM) 0.45Y avg ≈2.3 ≈2.3 2.5 Undervalued
P/B (MRQ) 0.85Y avg ≈1.2 ≈1.2 2.9 Undervalued
Price / FCF (TTM) 4.05Y avg ≈24.5 ≈24.5 · ·
Price / Cash Flow (TTM) 3.85Y avg ≈23.2 ≈23.2 12.7 Undervalued
Price / Tangible Book (MRQ) 7.5 · · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise 0.53%
Next Report Oct 27, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Jul 27, 2026 $-0.21 $-0.25 17.6%
March 31, 2026 $-0.36 $-0.32 -12.6%
Dec. 31, 2025 $-0.14 $-0.19 26.9%
Sept. 30, 2025 $-0.28 $-0.27 -3.2%
June 30, 2025 $-0.19 $-0.27 28.7%
March 31, 2025 $-0.53 $-0.34 -54.2%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 18
Metric Trend 202520242023202220212020201920182017201620152014
Revenue $2.53B$2.57B$2.60B$2.41B$2.03B$1.09B$553M$418M$233M$123M$77M$44M
Cost of Revenue ···$744M$650M$391M$184M$129M$62M$32M$21M$10M
Gross Profit ·······$289M$172M$91M$56M$34M
R&D Expense $278M$307M$349M$334M$312M$165M$65M$54M$34M$22M$14M$8M
SG&A Expense $432M$435M$465M$450M$438M$507M$164M$117M$80M$49M$43M$18M
Operating Expenses $2.79B$3.59B$2.85B$16.06B$2.30B$1.60B$634M$489M$309M···
Operating Income $-263M$-1.02B$-249M$-13.65B$-266M$-506M$-80M$-71M$-75M$-63M$-56M$-15M
Interest Expense ·$24M$22M$22M$81M·······
Interest Income $37M$57M$47M$13M$776.0K·······
Other Non-op $10M$-6M$4M$-859.0K$5M$-545.0K$342.0K·····
Pretax Income $-236M$-994M$-220M$-13.66B$-385M$-576M$-109M$-97M$-107M$-74M$-58M$-17M
Income Tax $-35M$8M$760.0K$-4M$44M$-91M$-11M$118.0K$-225.0K$510.0K$36.0K$388.0K
Net Income $-200M$-1.00B$-220M$-13.66B$-429M$-485M$-99M$-97M$-107M$-74M$-58M$-17M
EPS (Basic) $-1.14$-5.87$-1.34$-84.60$-2.73$-5.36$-1.38·····
EPS (Diluted) $-1.14$-5.87$-1.34$-84.60$-2.73$-5.36$-1.38·····
Shares (Basic) 176,221,530170,564,088164,578,219161,457,123156,939,34990,509,22971,844,535·····
Shares (Diluted) 176,221,530170,564,088164,578,219161,457,123156,939,34990,509,22971,844,535·····
EBITDA $-263M$-1.02B$-249M$-13.40B$-61M$-437M$-80M$-35M$-56M·$-51M·
Balance Sheet 28
Metric Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents $781M$1.30B$1.12B$918M$893M$733M$514M$424M$43M$50M$55M$46M
Short-term Investments ·······$55M$79M$16M$82M·
Receivables $193M$214M$217M$211M$169M$169M$57M$44M$27M$14M$12M$7M
Inventory $38M$38M$30M$56M$73M$56M$0·····
Prepaid Expense $107M$113M$118M$130M$87M$47M$14M$11M$7M$3M$2M$966.0K
Other Current Assets $2M$3M$7M$12M$6M·······
Current Assets $1.12B$1.66B$1.49B$1.32B$1.23B$1.06B$588M$533M$156M$83M$152M$54M
PP&E (Net) $27M$29M$32M$30M$27M$29M$10M$10M$9M$7M$6M$1M
PP&E (Gross) $112M$101M$92M$77M$61M$51M$26M$22M$17M$12M$8M$2M
Accum. Depreciation $85M$71M$60M$48M$34M$22M$16M$12M$8M$4M$2M$1M
Goodwill $283M$283M$1.07B$1.07B$14.50B$14.58B$746M$737M$499M$188M$56M$28M
Intangibles $1.30B$1.43B$1.68B$1.84B$1.91B$2.02B$225M$247M$160M$25M$15M$8M
Other Non-current Assets $106M$81M$80M$49M$21M$18M$7M$1M$858.0K$415.0K$293.0K$296.0K
Total Assets $2.86B$3.52B$4.39B$4.35B$17.73B$17.76B$1.60B$1.53B$824M$304M$230M$92M
Accounts Payable $48M$33M$44M$48M$47M$46M$9M$8M$4M$2M$2M$2M
Current Liabilities $405M$942M$421M$400M$331M$333M$90M$62M$40M$21M$18M$10M
Capital Leases $34M$32M$43M$38M$42M$43M$25M$0····
Deferred Tax $29M$50M$49M$51M$76M$102M$22M$32M$13M$2M$1M$482.0K
Other Non-current Liabilities $643.0K$720.0K$1M$2M$1M$2M$9M$6M$5M$8M$7M$3M
Total Liabilities $1.47B$2.03B$2.07B·········
Long-term Debt ·········$44M$26M$26M
Total Debt ····$0$43M····$26M·
Common Stock $178.0K$173.0K$167.0K$163.0K$160.0K$150.0K$73.0K$70.0K$61.0K$46.0K$38.0K$2.0K
Retained Earnings $-16.43B$-16.23B$-15.23B$-15.01B$-1.42B$-993M$-508M$-409M$-312M$-205M$-131M$-72M
AOCI $-35M$-38M$-37M$-43M$-6M$19M$-17M$-13M$4M$-1.0K$-42.0K·
Stockholders' Equity $1.39B$1.49B$2.33B$2.31B$16.05B$15.88B$1.01B$1.01B$559M$231M$179M$-68M
Liabilities + Equity $2.86B$3.52B$4.39B$4.35B$17.73B$17.76B$1.60B$1.53B$824M$304M$230M$92M
Shares Outstanding 178,315,400173,405,016166,658,253162,840,360160,469,325150,281,09972,761,94170,516,24961,534,10146,201,56338,524,9222,037,999
Cash Flow 18
Metric Trend 202520242023202220212020201920182017201620152014
D&A ···$256M$204M$69M$39M$36M$19M$8M$5M$2M
Stock-based Comp $80M$146M$202M$218M$303M$476M$67M$44M$31M$8M$3M$533.0K
Deferred Tax $-41M$-1M$-2M$-8M$41M$-91M$-11M$-2M$-591.0K$510.0K$36.0K$388.0K
Amort. of Intangibles $351M$363M$326M$245M$195M$65M$36M$32M$15M$6M$4M$2M
Restructuring $19M$20M$17M$7M···$1M····
Other Non-cash ···$13.38B$75M$-23M·$15M$23M·$3M·
Operating Cash Flow $294M$294M$350M$189M$194M$-54M$30M$-5M$-34M$-52M$-47M$-11M
CapEx $9M$11M$11M$16M$9M$4M$4M$4M$3M$2M$6M$1M
Investing Cash Flow $-266M$-124M$-156M$-168M$-73M$-591M$25M$-257M$-448M$26M$-108M·
Debt Issued ·······$10.0K$167M$35M$7M$20M
Net Debt Issued ······$0$10.0K$-60M·$468.0K·
Stock Issued ·····$0$0$331M$259M$250.0K$163M·
Stock Repurchased ···········$368.0K
Net Stock Activity ·····$0$0$331M$259M···
Financing Cash Flow $-552M$8M$11M$6M$41M$859M$35M$646M$475M$21M$164M·
Taxes Paid $9M$9M$7M$3M$4M$1M$1M$441.0K$137.0K···
Free Cash Flow $285M$283M$339M$173M$185M$-58M$26M$-9M$-37M·$-53M·
Levered FCF ·$259M$316M·········
Profitability 8
Metric Trend 202520242023202220212020201920182017201620152014
Gross Margin ·······69.2%73.6%·72.8%·
Operating Margin -10.4%-39.7%-9.6%-567.3%-13.1%-46.3%-14.5%-17.0%-32.3%·-72.1%·
Net Margin -7.9%-39.0%-8.5%-567.5%-21.1%-44.4%-17.9%-23.2%-45.8%·-75.0%·
Pretax Margin -9.3%-38.7%-8.4%-567.7%-18.9%-52.6%-19.8%-23.2%-45.9%·-74.9%·
EBITDA Margin -10.4%-39.7%-9.6%-556.6%-3.0%-39.9%-14.5%-8.4%-24.1%·-65.8%·
ROA -6.3%-25.3%-5.0%-123.7%-2.4%-5.0%-6.3%-8.2%-18.9%·-36.1%·
ROE -14.3%-66.8%-9.5%-326.8%-2.7%-5.4%-9.8%-9.5%-27.0%·-104.5%·
ROIC -16.1%-69.0%-10.7%-591.5%-1.8%-2.7%-7.2%-7.0%-13.5%·-27.2%·
Liquidity & Solvency 5
Metric Trend 202520242023202220212020201920182017201620152014
Current Ratio 2.81.83.53.33.73.26.58.53.9·8.4·
Quick Ratio 2.41.63.22.83.22.76.38.43.7·8.3·
Debt / Equity ····0.00.0····0.1·
LT Debt / Equity ··········0.1·
Interest Coverage ·-42.9-11.2·········
Efficiency 3
Metric Trend 202520242023202220212020201920182017201620152014
Asset Turnover 0.80.60.60.20.10.10.40.40.4·0.5·
Inventory Turnover ···11.510.013.8······
Receivables Turnover 12.411.912.212.712.09.711.011.811.4·8.2·
Per Share 5
Metric Trend 202520242023202220212020201920182017201620152014
Book Value / Share $7.77$8.60$13.96$14.17$99.99$105.69$13.94$14.37$9.08·$4.63·
Revenue / Share $14.36$15.07$15.81$14.91$12.95·······
Cash Flow / Share $1.67$1.72$2.13$1.17$1.24·······
Cash / Share $4.38$7.49$6.74$5.64$5.57$4.88$7.07$6.01$0.70·$1.43·
EPS (TTM) $-1.14$-5.87$-1.34$-84.60$-2.73$-5.36$-1.38·····
Growth Rates 3
Metric Trend 202520242023202220212020201920182017201620152014
Revenue YoY -1.5%-1.3%8.1%18.4%85.8%·······
Revenue CAGR 3Y 1.7%8.1%33.5%·········
Revenue CAGR 5Y 18.3%···········
Valuation (TTM) 13
Metric Trend 202520242023202220212020201920182017201620152014
Revenue TTM $2.53B$2.57B$2.60B$2.41B$2.03B$1.09B$553M$418M$233M$123M$77M·
Net Income TTM $-200M$-1.00B$-220M$-13.66B$-429M$-485M$-99M$-97M$-107M$-74M$-58M·
Market Cap $1.25B$1.58B$3.59B$3.85B$14.73B$30.05B$6.09B$3.50B$2.14B·$692M·
Enterprise Value ····$13.84B$29.36B····$581M·
P/E -6.1-1.5-16.1-0.3-33.6-37.3-60.7·····
P/S 0.50.61.41.67.227.511.08.49.2·8.9·
P/B 0.91.11.51.70.91.96.03.53.8·3.9·
P / Cash Flow 4.25.410.320.376.0-561.6203.9-719.2-62.3·-14.7·
P / FCF 4.45.610.622.379.4-522.3231.1-394.0-57.8·-12.9·
EV / EBITDA ····-225.4-67.2····-11.4·
EV / FCF ····74.6-510.3····-10.9·
EV / Revenue ····6.826.8····7.5·
Earnings Yield -16.3%-64.6%-6.2%-357.7%-3.0%-2.7%-1.7%·····

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $2.53B $2.57B $2.60B $2.41B $2.03B
Operating Margin % -10.4% -39.7% -9.6% -567.3% -13.1%
Net Income $-200M $-1.00B $-220M $-13.66B $-429M
Diluted EPS $-1.14 $-5.87 $-1.34 $-84.60 $-2.73

Institutional owners (13F) 392 filers · $1.5B total · As of Sept. 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 392
Value held $1.5B
New positions 65
Exited positions 34
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
65 (-2 vs prior Q) 34 (-38 vs prior Q) 111 (-8 vs prior Q) 94 (+9 vs prior Q) +11.8M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
VANGUARD GROUP INC $150,385,949 21,483,707 9.91% Shares
BlackRock, Inc. $137,572,176 16,223,134 9.07% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $107,573,820 12,685,592 7.09% Shares
Point72 Asset Management, L.P. $69,874,581 8,239,927 4.61% Shares
RENAISSANCE TECHNOLOGIES LLC $68,457,700 8,072,842 4.51% Shares
Voss Capital, LP $68,235,838 8,046,679 4.50% Shares
VANGUARD CAPITAL MANAGEMENT LLC $67,458,671 7,955,032 4.45% Shares
DIMENSIONAL FUND ADVISORS LP $62,515,646 7,371,699 4.12% Shares
STATE STREET CORP $42,080,999 4,962,382 2.77% Shares
AMERICAN CENTURY COMPANIES INC $41,505,394 4,894,504 2.74% Shares
Allianz Asset Management GmbH $39,572,734 4,666,596 2.61% Shares
GEODE CAPITAL MANAGEMENT, LLC $39,472,353 4,653,834 2.60% Shares
GOLDMAN SACHS GROUP INC $32,412,969 3,822,284 2.14% Shares
Monaco Asset Management SAM $26,864,462 3,167,979 1.77% Shares
JUPITER ASSET MANAGEMENT LTD $26,370,375 3,109,714 1.74% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $25,976,377 3,063,252 1.71% Shares
Quantinno Capital Management LP $23,904,416 2,818,917 1.58% Shares
FEDERATED HERMES, INC. $18,037,027 2,127,008 1.19% Shares
UBS Group AG $17,401,181 2,052,026 1.15% Shares
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $17,299,632 2,040,051 1.14% Shares
AMERIPRISE FINANCIAL INC $16,998,584 2,004,550 1.12% Shares
Pale Fire Capital SE $16,737,502 1,973,762 1.10% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $16,435,088 1,938,100 1.08% Call option
NORTHERN TRUST CORP $15,055,374 1,775,398 0.99% Shares
AQR CAPITAL MANAGEMENT LLC $14,855,924 1,751,878 0.98% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $11,710,032 1,380,900 0.77% Put option
BRIDGEWAY CAPITAL MANAGEMENT, LLC $11,348,708 1,338,291 0.75% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $11,229,479 1,324,231 0.74% Shares
MORGAN STANLEY $11,055,129 1,303,670 0.73% Shares
VANGUARD FIDUCIARY TRUST CO $10,120,074 1,193,405 0.67% Shares
BNP PARIBAS FINANCIAL MARKETS $9,796,800 1,155,283 0.65% Shares
FRANKLIN RESOURCES INC $9,710,439 1,145,099 0.64% Shares
Allspring Global Investments Holdings, LLC $9,024,853 991,742 0.59% Shares
Freestone Grove Partners LP $7,338,160 865,349 0.48% Shares
Man Group plc $6,880,545 811,385 0.45% Shares
PRINCIPAL FINANCIAL GROUP INC $6,827,859 805,172 0.45% Shares
CITADEL ADVISORS LLC $6,795,024 801,300 0.45% Put option
Union Square Park Capital Management, LLC $6,784,000 800,000 0.45% Shares
CITADEL ADVISORS LLC $6,532,093 770,294 0.43% Shares
FMR LLC $6,449,076 760,504 0.43% Shares
TCW GROUP INC $6,248,039 736,797 0.41% Shares
Voss Capital, LP $5,936,000 700,000 0.39% Call option
Empowered Funds, LLC $5,764,619 679,790 0.38% Shares
Bank of New York Mellon Corp $5,535,043 652,717 0.36% Shares
D. E. Shaw & Co., Inc. $5,420,493 639,209 0.36% Shares
PEAK6 LLC $5,227,920 616,500 0.34% Call option
CITADEL ADVISORS LLC $5,114,288 603,100 0.34% Call option
Squarepoint Ops LLC $5,089,696 600,200 0.34% Call option
JANE STREET GROUP, LLC $5,088,848 600,100 0.34% Put option
JPMORGAN CHASE & CO $4,283,818 484,856 0.28% Shares

Show all 392 institutional owners →

Activists & 5%+ owners 2 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Kinnevik AB (publ), Invik S.A. ×3 filings April 15, 2021 · Initial filing · SEC
General Catalyst Group Management Holdings GP, LLC, General Catalyst Group Management Holdings, L.P., General Catalyst Group Management, LLC, General Catalyst Group VI, L.P., General Catalyst Partners VI, L.P., General Catalyst GP VI, LLC, General Catalyst Group VIII, L.P., General Catalyst Group VIII Supplemental, L.P., General Catalyst Partners VIII, L.P., General Catalyst GP VIII, LLC, GC Partners Holdings, LP, GCSE VIII, L.P., GCSE VIII, LLC, GCGM Investment Holdings, LP, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow, Hemant Taneja ×3 filings March 16, 2021 · Initial filing · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 56 insiders · 29 officers · 24 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Charles Divita III CHIEF EXECUTIVE OFFICER Sept. 10, 2026 M 465,535 0 7 $-1,035,229
Laizer Kornwasser Advisor to the CEO Aug. 1, 2024 M 99,929 0 0 $0
Jason N Gorevic CHIEF EXECUTIVE OFFICER March 19, 2024 A 653,073 0 0 $0
Michael F Grasher Chief Financial Officer Sept. 1, 2026 A · 0 0 $0
Mala Murthy CHIEF FINANCIAL OFFICER Aug. 29, 2025 M 142,385 0 0 $0
Mark Hirschhorn Executive VP, COO and CFO Dec. 13, 2018 M 10,000 0 0 $0
Carlos Nueno President, International Sept. 1, 2026 M 64,744 0 4 $-218,769
Fernando M. Rodrigues President of BetterHelp Sept. 1, 2026 M 0 0 8 $-469,637
Kelly Bliss President, U.S. Group Health Sept. 1, 2026 M 92,832 0 7 $-343,192
Peter A Mcclennen President July 15, 2019 M 0 0 0 $0
Michael Willem Waters CHIEF OPERATING OFFICER Aug. 30, 2024 M 78,309 0 0 $0
David William Sides Chief Operating Officer July 29, 2021 M 11,031 0 0 $0
Joseph Ronald Catapano Chief Accounting Officer Sept. 1, 2026 M 12,865 0 7 $-48,940
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY Sept. 1, 2026 M 117,616 0 4 $-289,541
Vidya Raman-Tangella CHIEF MEDICAL OFFICER Sept. 4, 2024 S 33,665 0 0 $0
Andrew Turitz EVP, CORPORATE DEVELOPMENT Sept. 4, 2024 S 20,773 0 0 $0
James L. Cave INTERIM CAO Aug. 30, 2024 M 13,808 0 0 $0
Nikolaos P. Nanis Chief Technology Officer Aug. 30, 2024 M 75,410 0 0 $0
Arnnon Geshuri CHIEF PEOPLE OFFICER Aug. 30, 2024 M 44,914 0 0 $0
Daniel Trencher CHIEF STRATEGY OFFICER Aug. 30, 2024 M 31,465 0 0 $0
Stephany Verstraete CHIEF MARKETING OFFICER Aug. 30, 2024 M 48,843 0 0 $0
Richard J Napolitano CHIEF ACCOUNTING OFFICER March 19, 2024 A 18,077 0 0 $0
Claus Torp Jensen CHIEF INNOVATION OFFICER Dec. 1, 2023 M 20,703 0 0 $0
Lewis Levy Chief Medical Officer Oct. 1, 2020 M 8,766 0 0 $0
Michelle Bucaria Chief Human Resources Officer Sept. 1, 2020 M 3,232 0 0 $0
Christopher Caridi Chief Accounting Officer July 1, 2020 A · 0 0 $0
Gabriel R. Cappucci Senior VP, Controller and CAO April 16, 2020 M 988 0 0 $0
Michael H. King Chief Sales Officer May 25, 2017 A 61,459 0 0 $0
Peter N. Nieves EVP and CRO March 13, 2017 A · 0 0 $0
Mark V Anquillare Director Aug. 3, 2026 A · 0 0 $0
Catherine Jacobson Director May 21, 2026 A 66,853 0 0 $0
Mark Douglas Smith Director May 21, 2026 A 8,355 0 0 $0
Kenneth H Paulus Director May 21, 2026 A 10,000 1 0 $69,400
David B Snow JR Director May 21, 2026 A 113,032 0 0 $0
David L Shedlarz Director May 21, 2026 A 61,266 0 0 $0
Susan R Salka Director March 30, 2026 A · 0 0 $0
Michael S Smith Director Feb. 18, 2026 A · 0 0 $0
Jason Eric Evans Director Dec. 19, 2025 M 9,145 0 0 $0
Thomas Mckinley Director May 22, 2025 A 56,544 0 0 $0
Karen L Daniel Director May 22, 2024 M 36,995 0 0 $0
William H. Frist Director May 26, 2022 A 12,918 0 0 $0
Christopher Bischoff Director May 17, 2022 M 7,195 0 0 $0
Hemant Taneja Director April 19, 2021 S 118,760 0 0 $0
Glen Tullman Director April 1, 2021 M 275,793 0 0 $0
Helen Darling Director June 11, 2020 M 918 0 0 $0
Arneek Multani Director May 30, 2019 A 918 0 0 $0
Brian P Mcandrews Director May 30, 2019 A 1,965 0 0 $0
Tom Mawhinney Director May 25, 2018 M 46,203 0 0 $0
Martin R Felsenthal Director Aug. 8, 2016 A 10,860 0 0 $0
Dana G Mead Jr. Director Aug. 8, 2016 A 202 0 0 $0
James K Outland Director July 13, 2015 M 49,986 0 0 $0
CHP III Management, L.L.C. 10% owner April 26, 2017 J 2,480,468 0 0 $0
CHP III LP 10% owner April 26, 2017 J 2,480,468 0 0 $0
Sandra L Fenwick · May 21, 2026 A 12,070 0 0 $0
Yulun Wang · Jan. 25, 2021 S 219,507 0 0 $0
Michael Goldstein · June 11, 2020 M 0 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 37 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IHF · iShares Trust 0.16% 347,966 SH Sept. 11, 2026 Daily
VTWV · VANGUARD SCOTTSDALE FUNDS 0.10% 159,976 SH Aug. 19, 2026 Daily
DFSV · Dimensional ETF Trust 0.08% 1,038,485 NS July 31, 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0.05% 1,047,849 SH Aug. 19, 2026 Daily
ESML · iShares Trust 0.05% 219,811 SH Sept. 11, 2026 Daily
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0.05% 47,383 NS July 31, 2026 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0.04% 29,737 SH Aug. 19, 2026 Daily
RSSL · Global X Funds 0.04% 87,202 NS July 31, 2026 N-PORT
IWM · iShares Trust 0.04% 4,676,471 SH Sept. 11, 2026 Daily
VBR · VANGUARD INDEX FUNDS 0.03% 2,631,374 SH Aug. 19, 2026 Daily
PNQI · Invesco Exchange-Traded Fund Trust 0.03% 27,091 SH Oct. 2, 2026 Daily
DFAT · Dimensional ETF Trust 0.02% 528,876 NS July 31, 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.02% 2,084,219 SH Aug. 19, 2026 Daily
VB · VANGUARD INDEX FUNDS 0.02% 4,153,113 SH Aug. 19, 2026 Daily
VHT · VANGUARD WORLD FUND 0.02% 535,056 SH Aug. 19, 2026 Daily
FHLC · FIDELITY COVINGTON TRUST 0.02% 83,458 NS July 31, 2026 N-PORT
DFAS · Dimensional ETF Trust 0.01% 325,784 NS July 31, 2026 N-PORT
DXUV · Dimensional ETF Trust 0.01% 11,242 NS July 31, 2026 N-PORT
PRF · Invesco Exchange-Traded Fund Trust 0.01% 176,576 SH Oct. 2, 2026 Daily
WSML · iShares Trust 0.01% 10,496 SH Sept. 11, 2026 Daily
TILT · FlexShares Trust 0.01% 21,330 NS July 31, 2026 N-PORT
DFAC · Dimensional ETF Trust 0.01% 449,072 NS July 31, 2026 N-PORT
DFSU · Dimensional ETF Trust 0.01% 18,459 NS July 31, 2026 N-PORT
DCOR · Dimensional ETF Trust 0.00% 23,195 NS July 31, 2026 N-PORT
DSI · iShares Trust 0.00% 25,114 SH Sept. 10, 2026 Daily
DFUS · Dimensional ETF Trust 0.00% 82,328 NS July 31, 2026 N-PORT
DFAU · Dimensional ETF Trust 0.00% 43,186 NS July 31, 2026 N-PORT
ITOT · iShares Trust 0.00% 232,868 SH Sept. 11, 2026 Daily
IWV · iShares Trust 0.00% 45,761 SH Sept. 3, 2026 Daily
DFUV · Dimensional ETF Trust 0.00% 16,298 NS July 31, 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0.00% 5,687,282 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 15,175 SH Aug. 19, 2026 Daily
IWN · iShares Trust · 1,697,159 SH Sept. 11, 2026 Daily
SVAL · iShares Trust · 100,159 SH Sept. 3, 2026 Daily
ISCB · iShares Trust · 7,717 SH Sept. 11, 2026 Daily
ISCV · iShares Trust · 38,629 SH Sept. 11, 2026 Daily
SMLF · iShares Trust · 597,716 SH Sept. 11, 2026 Daily

TDOC Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 31 analysts HOLD
Median target $7.50 +35.9%
4 12.9% Strong Buy
7 22.6% Buy
20 64.5% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

17 analysts · 2026-10-02

Mean target $7.68 +39.1%

Now Current price $5.52
Low$5.50 Mean$7.68 High$10.50

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
TDOC $1.25B -6.1 -1.5% -7.9% -14.3% ·
HTFL $2.49B -9.2 39.9% -66.3% 39.3% 76.8%
SDGR · -12.7 23.3% -40.4% -29.2% 55.7%
CERT $1.40B -881.0 8.8% -0.38% -0.15% ·
GDRX · 30.1 0.57% 3.8% 4.8% ·
HSTM $682M 37.8 4.3% 6.0% 5.2% ·
PHR · 335.8 14.5% 0.48% 0.73% ·
CTEV $708M -2.5 3.7% -29.4% 265.9% ·
VEEV $33.40B 37.5 16.3% 28.4% 13.1% 75.5%

Latest News Recent headlines mentioning this company

23

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Jul 30, 2026